CN Patent

CN110433166A — 含有抗病毒活性二氢喹唑啉衍生物的药物制剂

Assigned to Aic246 Lianghe Co · Expires 2019-11-12 · 7y expired

What this patent protects

本发明涉及一种含有抗病毒活性二氢喹唑啉衍生物的药物制剂。具体地,本发明涉及药物制剂、尤其是用于静脉给药的药物制剂,其含有与选自环糊精、赖氨酸和精氨酸中的至少一种助剂组合的{8‑氟‑2‑[4‑(3‑甲氧基苯基)哌嗪‑1‑基]‑3‑[2‑甲氧基‑5‑(三氟甲基)苯基]‑3,4‑二氢喹唑啉‑4‑基}乙酸,涉及其生产方法,和涉及其治疗和/或预防疾病的用途,尤其是其作为抗病毒剂、优选地针对巨细胞病毒的用途。

USPTO Abstract

本发明涉及一种含有抗病毒活性二氢喹唑啉衍生物的药物制剂。具体地,本发明涉及药物制剂、尤其是用于静脉给药的药物制剂,其含有与选自环糊精、赖氨酸和精氨酸中的至少一种助剂组合的{8‑氟‑2‑[4‑(3‑甲氧基苯基)哌嗪‑1‑基]‑3‑[2‑甲氧基‑5‑(三氟甲基)苯基]‑3,4‑二氢喹唑啉‑4‑基}乙酸,涉及其生产方法,和涉及其治疗和/或预防疾病的用途,尤其是其作为抗病毒剂、优选地针对巨细胞病毒的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN110433166A
Jurisdiction
CN
Classification
Expires
2019-11-12
Drug substance claim
No
Drug product claim
No
Assignee
Aic246 Lianghe Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.